Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial

Timothy Iveson, Mark P. Saunders, Caroline Kelly, Rachel S. Kerr, Jim Cassidy, Niels Henrik Hollander, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Sarah Pearson, Kathleen A. Boyd, Andrew H. Briggs, Ashita Waterston, Louise Medley, Richard Ellis, Amandeep S. Dhadda, Mark Harrison, Stephen Falk, Charlotte Rees, Rene K. Olesen, David Propper, John Bridgewater, Ashraf Azzabi, David Cunningham, Tamas Hickish, Simon Gollins, Harpreet S. Wasan, David Church, Enric Domingo

Open source

DOI: 10.1200/jco-25-00621
Published: 2026-03-01
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-00621,
  title = {Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial},
  author = {Timothy Iveson and Mark P. Saunders and Caroline Kelly and Rachel S. Kerr and Jim Cassidy and Niels Henrik Hollander and Josep Tabernero and Andrew Haydon and Bengt Glimelius and Andrea Harkin and Karen Allan and John McQueen and Sarah Pearson and Kathleen A. Boyd and Andrew H. Briggs and Ashita Waterston and Louise Medley and Richard Ellis and Amandeep S. Dhadda and Mark Harrison and Stephen Falk and Charlotte Rees and Rene K. Olesen and David Propper and John Bridgewater and Ashraf Azzabi and David Cunningham and Tamas Hickish and Simon Gollins and Harpreet S. Wasan and David Church and Enric Domingo},
  year = {2026},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco-25-00621},
  url = {https://doi.org/10.1200/jco-25-00621}
}

RIS

TY  - JOUR
TI  - Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial
AU  - Timothy Iveson
AU  - Mark P. Saunders
AU  - Caroline Kelly
AU  - Rachel S. Kerr
AU  - Jim Cassidy
AU  - Niels Henrik Hollander
AU  - Josep Tabernero
AU  - Andrew Haydon
AU  - Bengt Glimelius
AU  - Andrea Harkin
AU  - Karen Allan
AU  - John McQueen
AU  - Sarah Pearson
AU  - Kathleen A. Boyd
AU  - Andrew H. Briggs
AU  - Ashita Waterston
AU  - Louise Medley
AU  - Richard Ellis
AU  - Amandeep S. Dhadda
AU  - Mark Harrison
AU  - Stephen Falk
AU  - Charlotte Rees
AU  - Rene K. Olesen
AU  - David Propper
AU  - John Bridgewater
AU  - Ashraf Azzabi
AU  - David Cunningham
AU  - Tamas Hickish
AU  - Simon Gollins
AU  - Harpreet S. Wasan
AU  - David Church
AU  - Enric Domingo
PY  - 2026
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco-25-00621
UR  - https://doi.org/10.1200/jco-25-00621
ER  -

APA

Iveson, T., Saunders, M. P., Kelly, C., Kerr, R. S., Cassidy, J., Hollander, N. H., Tabernero, J., Haydon, A., Glimelius, B., Harkin, A., Allan, K., McQueen, J., Pearson, S., Boyd, K. A., Briggs, A. H., Waterston, A., Medley, L., Ellis, R., Dhadda, A. S., Harrison, M., Falk, S., Rees, C., Olesen, R. K., Propper, D., Bridgewater, J., Azzabi, A., Cunningham, D., Hickish, T., Gollins, S., Wasan, H. S., Church, D., & Domingo, E. (2026). Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00621

Source records

crossref · retrieved 2026-09-26T02:39:04.088Z